Fisher D M, Canfell P C, Fahey M R, Rosen J I, Rupp S M, Sheiner L B, Miller R D
Anesthesiology. 1986 Jul;65(1):6-12.
Atracurium, a nondepolarizing muscle relaxant, is eliminated through several pathways, including Hofmann elimination (spontaneous degradation in plasma and tissue at normal body pH and temperature) and ester hydrolysis (catalysis by nonspecific esterases). Because elimination of atracurium occurs in both tissue and plasma, traditional pharmacokinetic models assuming elimination from a single central compartment are inaccurate for atracurium. The authors developed a two-compartment pharmacokinetic model in which hepatic and/or renal elimination occurs from the central compartment (Cl organ), and Hofmann elimination and ester hydrolysis occur from both central and peripheral compartments (Cl nonorgan). To determine the in vitro rate constant for Hofmann elimination and ester hydrolysis, atracurium was added to whole blood kept at each patient's pH and temperature. The values for this rate constant ranged from 0.0193 to 0.0238 per min. When these values were applied to the pharmacokinetic model, Cl total, Cl organ, and Cl nonorgan were 4.8 +/- 1.1, 3.0 +/- 0.9, and 1.9 +/- 0.6 ml . kg-1 . min-1, respectively. The authors conclude that more than one-half of the clearance of atracurium occurs via pathways other than Hofmann elimination and ester hydrolysis.
阿曲库铵是一种非去极化型肌松药,可通过多种途径消除,包括霍夫曼消除(在正常体温及生理pH值下于血浆和组织中自发降解)和酯水解(由非特异性酯酶催化)。由于阿曲库铵在组织和血浆中均可被消除,因此传统的单室消除药代动力学模型对阿曲库铵并不适用。作者建立了一个双室药代动力学模型,其中肝和/或肾消除发生于中央室(Cl器官),霍夫曼消除和酯水解则发生于中央室和外周室(Cl非器官)。为了确定霍夫曼消除和酯水解的体外速率常数,将阿曲库铵添加到维持于各患者体温及pH值的全血中。该速率常数的值为每分钟0.0193至0.0238。当将这些值应用于药代动力学模型时,总清除率(Cl总)、器官清除率(Cl器官)和非器官清除率(Cl非器官)分别为4.8±1.1、3.0±0.9和1.9±0.6 ml·kg⁻¹·min⁻¹。作者得出结论,阿曲库铵清除率的一半以上并非通过霍夫曼消除和酯水解途径。